Skip to main content

Table 2 Comparison of C. auris infected patients with C. auris colonizers

From: Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan

Variable Infection (n = 65) Colonization (n = 27) p-value
Male 35 (53.8%) 13 (48.1%) 0.85
Age group
 16–35 15 (23.1%) 5 (18.5%)  
 36–55 20 (30.8%) 6 (22.2%) 0.51
 56–75 21 (32.3%) 9 (33.3%)  
 76–95 9 (13.8%) 7 (25.9%)  
ICU 23 (35.4%) 7 (25.9%) 0.12
HDU 24 (36.9%) 6 (22.2%)  
Ward 11 (40.7%) 16 (24.6%)  
DM 18 (27.7%) 8 (29.6%) 0.85
Malignancy 13 (20%) 5 (18.5%) 0.80
Surgery 39 (60%) 14 (51.9%) 0.61
Co-infection with MDR bacteria 22 (33.8%) 7 (25.9%) 0.45
Appropriate antifungal therapy 44 (67.7%) 0 < 0.001
Source control 40 (61.5%) 7 (25.9%) < 0.001
Mortality 30 (46.2%) 9 (33.3%) 0.25
14-day mortality 23 (35.4%) 6 (22.2%) 0.45
Clinical failure 24 (64.9%) 6 (22.2%) < 0.001
Alive 35 (53.8%) 18 (66.7%)  
C. auris death 19 (29.2%) 0  
Non-auris death 11 (16.9%) 9 (33.3%) 0.005